ConductScience.org, home

Paper38278784

Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice.

Dos Santos Alves RP and 21 others. Nat Commun, 2024. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice. Papers, record 38278784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38278784

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice.
PubMed
Journal
Nat Commun
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
2.29, provisional
iCite
Revised in PubMed
2026-09-22
PubMed

Authors22

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dos Santos Alves RPRúbens Princehttps://orcid.org/0000-0001-5538-6025
2Timis JJulia
3Miller RRobyn
4Valentine KKristen
5Pinto PBAPaolla Beatriz Almeida
6Gonzalez AAndrew
7Regla-Nava JAJose Angel
8Maule EErin
9Nguyen MNMichael Nhttps://orcid.org/0000-0002-4184-7078
10Shafee NNorazizahhttps://orcid.org/0000-0002-6877-7612
11Landeras-Bueno SSara
12Olmedillas EEduardo
13Laffey BBrett
14Dobaczewska KKatarzynahttps://orcid.org/0000-0002-6377-018X
15Mikulski ZZbigniew
16McArdle SSarahttps://orcid.org/0000-0003-3795-3772
17Leist SRSarah Rhttps://orcid.org/0000-0002-4989-5381
18Kim KKennethhttps://orcid.org/0000-0002-5993-4575
19Baric RSRalph Shttps://orcid.org/0000-0001-6827-8701
20Ollmann Saphire EEricahttps://orcid.org/0000-0002-1206-7451

Source PubMed

See all 22 authorsDownload CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
Coronavirus OC43, HumanMajor topic
Humans
Mice
Animals
SARS-CoV-2
Mice, Transgenic
HLA-DRB1 Chains
CD4-Positive T-Lymphocytes
Spike Glycoprotein, Coronavirus

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 AI007036NIAID NIH HHSUnited StatesT32AI007036PubMed and NIHNIH RePORTER
U01 AI149644NIAID NIH HHSUnited StatesU01AI149644PubMed and NIHNIH RePORTER
U01 AI151810NIAID NIH HHSUnited StatesU01AI151810PubMedNIH RePORTER
U19 AI142790NIAID NIH HHSUnited StatesU19AI142790PubMed and NIHNIH RePORTER

Download CSV of grants

References147

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133853928SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients.Sci Immunol2021https://conductscience.org/library/papers/33853928PubMed
235314848Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory.Nat Immunol2022https://conductscience.org/library/papers/35314848PubMed
329427907Human coronavirus circulation in the United States 2014-2017.J Clin Virol2018https://conductscience.org/library/papers/29427907PubMed
435857703ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies.Science2022https://conductscience.org/library/papers/35857703PubMed
535224466No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults.iScience2022https://conductscience.org/library/papers/35224466PubMed
632475066Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS-CoV-2.Curr Protoc Microbiol2020https://conductscience.org/library/papers/32475066PubMed
732668444SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.Nature2020https://conductscience.org/library/papers/32668444PubMed
834010947Diverse functional autoantibodies in patients with COVID-19.Nature2021https://conductscience.org/library/papers/34010947PubMed
933331927SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.Blood2020https://conductscience.org/library/papers/33331927PubMed
1032459916Hospitalization and Mortality among Black Patients and White Patients with Covid-19.N Engl J Med2020https://conductscience.org/library/papers/32459916PubMed
1132979816Protective and enhancing interactions among dengue viruses 1-4 and Zika virus.Curr Opin Virol2020https://conductscience.org/library/papers/32979816PubMed
1236917669Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/36917669PubMed
1334465633Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.Science2021https://conductscience.org/library/papers/34465633PubMed
1433457109Decoding Covid-19 with the SARS-CoV-2 Genome.Curr Genet Med Rep2021https://conductscience.org/library/papers/33457109PubMed
1533159009Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.Science2020https://conductscience.org/library/papers/33159009PubMed
1632997649Recent endemic coronavirus infection is associated with less-severe COVID-19.J Clin Invest2021https://conductscience.org/library/papers/32997649PubMed
1733293664Older adults lack SARS CoV-2 cross-reactive T lymphocytes directed to human coronaviruses OC43 and NL63.Sci Rep2020https://conductscience.org/library/papers/33293664PubMed
1831075077Cross-Protection of Dengue Virus Infection against Congenital Zika Syndrome, Northeastern Brazil.Emerg Infect Dis2019https://conductscience.org/library/papers/31075077PubMed
1933031744A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.Cell2020https://conductscience.org/library/papers/33031744PubMed
2037468623A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.Nature2023https://conductscience.org/library/papers/37468623PubMed

See all 147 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42903838Conserved nucleocapsid epitopes induce cross-reactive CD4+ T-cell responses with selective protection against human coronaviruses in mice.Hlife2026https://conductscience.org/library/papers/42903838PubMed
41295541Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses.Vaccines (Basel)2025https://conductscience.org/library/papers/41295541PubMed
41123344Development of a cross-protective common cold coronavirus vaccine.J Virol2025https://conductscience.org/library/papers/41123344PubMed
41012619T-Cell Epitope-Based SARS-CoV-2 DNA Vaccine Encoding an Antigen Fused with Type 1 Herpes Simplex Virus Glycoprotein D (gD).Viruses2025https://conductscience.org/library/papers/41012619PubMed
40910046Prepandemic levels of cytokines and immunoglobulins and risk of SARS-CoV-2 infection and COVID-19 in the general population of Barcelona.Front Public Health2025https://conductscience.org/library/papers/40910046PubMed
40690526Population-level toggling of T cell immune escape at human leukocyte antigen anchor residues in SARS-CoV-2 Spike proteins, in an ethnically diverse population region.PLoS Comput Biol2025https://conductscience.org/library/papers/40690526PubMed
40494917T-cell responses induced by SARS-CoV-2 index-virus nanoparticle protein vaccine to the ancestral and omicron variants 6 months following primary vaccination.Commun Med (Lond)2025https://conductscience.org/library/papers/40494917PubMed
40446030Proteomic signatures of corona and herpes viral antibodies identify IGDCC4 as a mediator of neurodegeneration.Sci Adv2025https://conductscience.org/library/papers/40446030PubMed
40387363Endemic coronavirus infection is associated with SARS-CoV-2 Fc receptor-binding antibodies.J Virol2025https://conductscience.org/library/papers/40387363PubMed
40313411Phylogenetic and epidemiological insights into centenarians' resilience to COVID-19: exploring the role of past coronavirus pandemics.Front Microbiol2025https://conductscience.org/library/papers/40313411PubMed
40191213Enhanced and long-lasting SARS-CoV-2 immune memory in individuals with common cold coronavirus cross-reactive T cell immunity.Front Immunol2025https://conductscience.org/library/papers/40191213PubMed
39743545The guided fire from within: intratumoral administration of mRNA-based vaccines to mobilize memory immunity and direct immune responses against pathogen to target solid tumors.Cell Discov2025https://conductscience.org/library/papers/39743545PubMed
39702529Co-immunization with spike and nucleocapsid based DNA vaccines for long-term protective immunity against SARS-CoV-2 Omicron.NPJ Vaccines2024https://conductscience.org/library/papers/39702529PubMed
39625929Comparison of a SARS-CoV-2 mRNA booster immunization containing additional antigens to a spike-based mRNA vaccine against Omicron BA.5 infection in hACE2 mice.PLoS One2024https://conductscience.org/library/papers/39625929PubMed
39353281Influence of Th1 versus Th2 immune bias on viral, pathological, and immunological dynamics in SARS-CoV-2 variant-infected human ACE2 knock-in mice.EBioMedicine2024https://conductscience.org/library/papers/39353281PubMed
39157328Bioinformatic elucidation of conserved epitopes to design a potential vaccine candidate against existing and emerging SARS-CoV-2 variants of concern.Heliyon2024https://conductscience.org/library/papers/39157328PubMed
38966641Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming.Front Immunol2024https://conductscience.org/library/papers/38966641PubMed
38865483Heterotypic immunity from prior SARS-CoV-2 infection but not COVID-19 vaccination associates with lower endemic coronavirus incidence.Sci Transl Med2024https://conductscience.org/library/papers/38865483PubMed
38793729Harnessing T-Cells for Enhanced Vaccine Development against Viral Infections.Vaccines (Basel)2024https://conductscience.org/library/papers/38793729PubMed
38611624Long COVID: Long-Term Impact of SARS-CoV2.Diagnostics (Basel)2024https://conductscience.org/library/papers/38611624PubMed

See all 21 cited byDownload CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38278784

GET https://conductscience.org/api/papers/v1/38278784/authors?page=2